Vanguard Capital Management
KRRO icon

Vanguard Capital Management’s Korro Bio KRRO Stock Holding History

Vanguard Capital Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.99M Buy
454,778
+143,865
+46% +$1.79M ﹤0.01% 3050
2026
Q1 		$3.52M Buy
+310,913
New +$3.42M ﹤0.01% 3187

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management's KRRO Position: Q2 2026 in Review

Vanguard Capital Management increased its Korro Bio (KRRO) stake by 46% in Q2 2026, buying an estimated $1.79M and bringing the position to 454,778 shares worth $5.99M. The position accounts for ﹤0.01% of the portfolio, ranked #3050.

Vanguard Capital Management first reported a position in KRRO in Q1 2026 and has held it in 2 quarters since. 97 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Vanguard Capital Management held 454,778 shares of Korro Bio worth $5.99M as of Q2 2026.
  • Vanguard Capital Management bought 143,865 Korro Bio shares in Q2 2026, an estimated $1.79M.
  • Korro Bio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3050 holding.
  • Vanguard Capital Management first reported a position in Korro Bio in Q1 2026 and has held it in 2 quarters since.
  • 97 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.